Law360 Notes Special Counsel Joseph D. Wilson as Representation for Lupin Pharmaceuticals
May 5, 2014

Special Counsel Joseph D. Wilson was noted as counsel for Lupin Pharmaceuticals in the Law360 article “Lupin Blasts FDA's Call On Celebrex Generic Exclusivity.” The article discusses how Lupin has sued the U.S. Food and Drug Administration in Maryland federal court over the agency’s decision to grant another drug company exclusivity to make a generic version of Pfizer Inc.’s Celebrex, arguing the decision was wrong because the exclusivity period had already expired five years ago. Lupin's suit also goes after Mylan and Watson for their request in their lawsuits to be granted shared exclusivity with Teva, saying the request was irrelevant because there can be only one exclusivity period.